Dr. Wolfgang Plischke is a Member at Helmholtz-Gemeinschaft Deutscher Forschungszentren eV, a Chairman-Supervisory Board at Evotec AG, a Council Member at University of Hohenheim, a Member-Executive Board at Robert Koch Stiftung eV, a Member-Executive Board at Walter Siegenthaler Gesellschaft, a Chairman-Supervisory Board at Bayer Innovation GmbH, a Chairman-Supervisory Board at Bayer Real Estate GmbH, a Chairman-Supervisory Board at Bayer Technology Services GmbH, a Member-Executive Board at Bundesverband der Deutschen Industrie e.V., a Member-Executive Board at German Asia Pacific Business Association and a Vice President at European Chemical Industry Council.
He is on the Board of Directors at Bayer AG, German Chemical Industry Fund and Paul Ehrlich-Foundation. Dr. Plischke was previously employed as a Chairman-Management Board by Bayer HealthCare AG, an Independent Non-Executive Director by Ark Therapeutics Group Plc, a Member-Management Board by Bayer AG, a President by Bayer Yakuhin Ltd., a Head-Marketing by Bayer Schering Pharma AG, a Chairman-Supervisory Board by Covestro AG, and a Chairman by Verband Forschender Arzneimittelhersteller e.V.
He also served on the board at Ludwig Heilmeyer Society.
He received his undergraduate degree from the University of Hohenheim and a doctorate degree from the University of Hohenheim.